Carcinoma, Hepatocellular: all 3,249 studies

Page 24 of 33. Open to participants first (974), then studies with results posted, then the rest; newest registration first within each.

• Adjuvant Therapy With Apatinib for HCC Patients With PVTT Who Underwent Radical ResectionStatus unknownNCT03261791Phase 2
• Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder CancerActive, not recruitingNCT03257761Phase 1
• Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological ResponseCompletedNCT03254121
• Meclizine for Hepatocellular CarcinomaCompletedNCT03253289Phase 1
• The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by ResectionStatus unknownNCT03253250Phase 4
• Study of the Early Occurrence of Hepatocellular Carcinoma (HCC) in Egyptian HCV Infected Patients Receiving Sofosbuvir and DaclatasvirStatus unknownNCT03247296
• Study of Chiauranib in Patients With Advanced Hepatocellular CarcinomaCompletedNCT03245190Phase 1/2
• Targeted and Staged Cyber Knife Combined With Interventional Therapy in the Treatment of MHCCStatus unknownNCT03243916Not applicable
• The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma SubjectsTerminatedNCT03236649Phase 3
• The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma SubjectsStatus unknownNCT03236636Phase 3
• Cytidine-phosphate-guanosine (CpG) DNA in Hepatocellular Carcinoma Combination TherapyStatus unknownNCT03235167Phase 1
• Hepatocellular Carcinoma Registry in Asia: The INSIGHT RegistryCompletedNCT03233360
• QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint InhibitorsActive, not recruitingNCT03228667Phase 2
• MicroRNAs as Diagnostic Biomarkers in Hepatocellular Carcinoma Among Somali PatientsStatus unknownNCT03227510
• Tazemetostat in Treating Patients With Metastatic or Unresectable Solid Tumors or B-Cell Lymphomas With Liver DysfunctionWithdrawnNCT03217253Phase 1
• Trans-parenchymal Compressing Suture in Major Liver ResectionCompletedNCT03215290Not applicable
• The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin ReactionCompletedNCT03212625Phase 4
• Surefire Institutional DEB-TACEStatus unknownNCT03211598Not applicable
• Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC)Status unknownNCT03208335Phase 2
• Role of Serum Regucalcin in Diagnosis of Hepatocellular CarcinomaStatus unknownNCT03206866
• Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere®TerminatedNCT03203837
• Stereotactic Body Radiotherapy (SBRT) Followed by Immunotherapy in Liver CancerTerminatedNCT03203304Phase 1
• IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma PatientsCompletedNCT03203005Phase 1/2
• Effect of DAAs on Behavior of HCC in HCV PatientsCompletedNCT03200171
• Preoperative Prediction of Microvascular Invasion in Hepatocellular CarcinomaStatus unknownNCT03198975
• Direct-acting Antivirals and Hepatocellular Carcinoma RecurrenceCompletedNCT03197155
• Oral STAT3 Inhibitor, TTI-101, in Patients with Advanced CancersCompletedNCT03195699Phase 1
• The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.Status unknownNCT03192644Phase 3
• The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.Status unknownNCT03192618Phase 3
• Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma With Solitary Huge TumorStatus unknownNCT03191123Not applicable
• Study of TCM Syndrome of Hepatocellular Carcinoma and Colorectal Cancer Based on System ScienceStatus unknownNCT03189992Phase 1
• Radiation Therapy With Protons or Photons in Treating Patients With Liver CancerActive, not recruitingNCT03186898Phase 3
• Celebrex and Metformin for Postoperative Hepatocellular CarcinomaStatus unknownNCT03184493Phase 3
• Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic CarcinomaStatus unknownNCT03178929Not applicable
• Combined HCC-MFCCCCompletedNCT03178409
• Evaluation of Pathway Modulation by Raf, MEK, & Kinase InhibitorsCompletedNCT03176485Not applicable
• Adoptive Transfer of Specific HCC Antigens CD8+ T Cells for Treating Patients With Relapsed/Advanced HCCStatus unknownNCT03175705Phase 1
• Radiotherapy Versus no Intervention in Adult Patients With Hepatocellular Carcinoma Not Eligible for Transarterial Chemoembolization or Ablation Prior to Liver Transplant (RADBRI)WithdrawnNCT03172559Not applicable
• Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsActive, not recruitingNCT03170960Phase 1
• Randomized Trial Comparing Stereotactic Body Radiation Therapy to Microwave Ablation for the Treatment of Localized Hepatocellular CarcinomaWithdrawnNCT03168152Not applicable
• Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT03164382Phase 3
• Transradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Outcomes and Satisfaction (BEST ACCESS Trial).CompletedNCT03163186
• Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)CompletedNCT03162198
• Chronic Hepatitis B Virus Infection in ZambiaCompletedNCT03158818
• Impacts of the α-fetoprotein (AFP) Score in Real Life for Patient Selection for Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC)CompletedNCT03156582
• Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver TumorsStatus unknownNCT03149523
• CAR-GPC3 T Cells in Patients With Refractory Hepatocellular CarcinomaCompletedNCT03146234Not applicable
• TATE Versus TACE in Intermediate Stage HCCTerminatedNCT03145558Phase 2
• An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other MalignanciesTerminatedNCT03144661Phase 1
• The Effect of Percutaneous Radiofrequency Ablation of Feeding Arterial for Hepatocellular CarcinomaStatus unknownNCT03143140Not applicable
• Contribution of the Perfusion Scanner in the Prediction of the Tumor Control of Patients With Hepatocellular Carcinoma Treated With Sorafenib.CompletedNCT03140332Not applicable
• Combined Ipsilateral Liver Lobe Devascularization and Alcohol Treatment of the Large Hepatocellular CarcinomaStatus unknownNCT03138044Not applicable
• Percutaneous Ethanol Alcohol Injection for the Large and Unresectable Hepatocellular CarcinomaCompletedNCT03138031Not applicable
• Impact of Three-dimensional Visualization on Operation Strategy and Complications for Complex Hepatic CarcinomaStatus unknownNCT03132740
• A Study of GPC3-targeted T Cells by Intratumor Injection for Advanced HCC (GPC3-CART)Status unknownNCT03130712Phase 1/2
• Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular CarcinomaStatus unknownNCT03129685Not applicable
• A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFAStatus unknownNCT03124498Phase 1/2
• A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCCStatus unknownNCT03116984Phase 3
• Novel Gallium Imaging in Hepatocellular CarcinomaStatus unknownNCT03116945Phase 2
• Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular CarcinomaStatus unknownNCT03114085Phase 2
• Analysis of the Role of Hepatocyte SLAMF3 Receptor and Drug Resistance Proteins (MDR) in Resistance to Treatment With Sorafenib in CHC PatientsWithdrawnNCT03113604
• Preoperative Estimation of Microvascular Invasion in Hepatocellular CarcinomaStatus unknownNCT03110068
• Study of Milciclib in Patients With Unresectable/Metastatic Hepatocellular CarcinomaCompletedNCT03109886Phase 2
• Pembrolizumab Plus Y90 Radioembolization in HCC SubjectsStatus unknownNCT03099564Early Phase 1
• Efficacy and Safety of Sorafenib as Adjuvant and Latter Radiofrequency Ablation for Recurrent Hepatocellular CarcinomaStatus unknownNCT03097848Not applicable
• HCC Response Assessment by MRI After SBRTCompletedNCT03088423
• Anti-GPC3 CAR-T for Treating GPC3-positive Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT03084380Phase 1/2
• Risk of Hepatocellular Carcinoma in Patient With Liver CirrhosisStatus unknownNCT03083002
• Central Obesity and Hepatocellular CarcinomaStatus unknownNCT03082378
• FLNA in HCC PatientsCompletedNCT03081637
• Transarterial Chemoembolization (TACE) With or Without Stereotactic Body Radiotherapy (SBRT) in Hepatocellular CarinomaWithdrawnNCT03079778Not applicable
• Mutational Landscape in Hepatocellular CarcinomaCompletedNCT03071458
• Clemizole HCl for Subjects With Hepatocellular CarcinomaStatus unknownNCT03069508Phase 2
• Study of the Combination of TACE With Apatinib in Patients With Hepatocellular CarcinomaStatus unknownNCT03066557Not applicable
• HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/BCompletedNCT03048123Phase 2
• Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCCCompletedNCT03047603
• Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC)Status unknownNCT03046979Phase 2
• Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Liver Cancer Receiving Transarterial Chemoembolization With Drug Eluting BeadsCompletedNCT03045497Phase 1
• Immunological Response After Ablative Therapy in the LiverWithdrawnNCT03040453Not applicable
• Golgi Protein for HCC DiagnosisCompletedNCT03039322
• Lipotecan Based Concurrent Chemoradiotherapy in Hepatocellular Carcinoma With Portal Vein Tumor ThrombosisTerminatedNCT03035006Phase 1/2
• Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular CarcinomaCompletedNCT03033446Phase 2
• Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver CancerActive, not recruitingNCT03028311Phase 1
• Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative TreatmentActive, not recruitingNCT03024684Phase 4
• HBV-host cfDNA as Minimal Residual Tumor Marker for HBV-related HCCStatus unknownNCT03020342
• Paediatric Hepatic International Tumour TrialActive, not recruitingNCT03017326Phase 3
• A Clinical Research of CAR T Cells Targeting EpCAM Positive CancerStatus unknownNCT03013712Phase 1/2
• Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor ThrombosisCompletedNCT03009461Phase 2
• A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of SorafenibTerminatedNCT03008512Phase 2
• Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver CancerCompletedNCT03008343Phase 1/2
• Outcome of Transarterial Chemo-embolization (TACE) in Hepatocellular Carcinoma Patients With Partial Portal Vein ThrombosisCompletedNCT03007212Phase 4
• Needle Guiding Robot for Radiofrequency Ablation: Safety and Efficacy Study on Hepatocellular Carcinoma PatientsStatus unknownNCT03005756Not applicable
• Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE)WithdrawnNCT02997956Phase 1/2
• Tumor Characteristics, Pre-transplant Treatments and Immunosuppression After Liver Transplantation for Hepatocellular CarcinomaCompletedNCT02995096
• Efficacy of Loco-regional Treatment for Hepatocellular Carcinoma Prior to Living Donor Liver Transplantation in EgyptCompletedNCT02990351
• Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular CarcinomaWithdrawnNCT02989870Phase 1
• Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular PatientsCompletedNCT02988440Phase 1
• The Impact on Therapeutic Effect and Tolerance of Treatment for Patients With Hepatocellular Carcinoma in Transcatheter Arterial Chemoembolization (TACE) of Dexamethasone Application: A Random, Double-blind, Controlled, Clinical Trial.Status unknownNCT02987907Phase 3
• Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-FluorouracilStatus unknownNCT02987699Phase 2
• Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)Active, not recruitingNCT02984566Not applicable

← Carcinoma, Hepatocellular overview